Reaching New Heights in Nuclear Medicine





March 1-4, 2025

HCNMC will be in-person for the 2025 High Country Nuclear Medicine Conference in Park City, UT.

The HCNMC is committed to ensuring that appropriate health and safety protocols are in place for this event. We will follow all Centers for Disease Control and Prevention (CDC) safety protocols and recommendations and will comply with all federal, state and local regulations. 

High Country continues to attract and blend experts from academia and industry, with leaders in medical specialties, the regulatory agencies and health care researchers in an informal setting to facilitate dialog and an exchange of ideas. The meeting consists of six to seven hours of structured sessions per day (8 sessions total). In between sessions, roundtable discussions will be held and there are ample opportunities for independent meetings and networking.



Thank you to our 2025 Sponsors!


Featured Sponsors

Bracco Diagnostics Inc. (BDI), the U.S.-based subsidiary of Bracco Imaging SpA, and part of the Bracco Group, is a leader in innovative imaging agents. Bracco offers a product and solution portfolio for all key diagnostic imaging modalities: X-Ray Imaging, Magnetic Resonance Imaging (MRI), Contrast Enhanced Ultrasound (CEUS), and Nuclear Medicine through radioactive tracers.

Bracco nuclear medicine offers specialty radiopharmaceuticals for cardiac PET and hepatobiliary imaging. A decades-long legacy of excellence through research, innovation and clinical expertise has earned Bracco a reputation as the market leader in cardiac PET imaging.

Find out how our solutions, expertise and experience can help you and your patients.


Lantheus Medical Imaging ( is a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products. 


Contributor Sponsors